483
Novacyl RoussillonNovacyl Roussillon – FDA 483, Jun 27, 2016
Record Details
Novacyl, an active pharmaceutical manufacturer in Roussillon, France, received two observations during an FDA inspection in June 2016. The firm failed to thoroughly review batch failures related to impurity specifications for an API, and also had issues with equipment maintenance, including leaks and malfunctions, which contributed to product impurity failures. These observations indicate deficiencies in quality control and equipment management practices.
View Company Profile
ID · a2aae6a4-8c12-4fb5-b36f-b3ff7771f9ed
Other documents for Novacyl Roussillon
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.